Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.
about
B cell receptor signaling regulates metabolism in Chronic Lymphocytic Leukemia.Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199).Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia.Recent therapeutic advances in chronic lymphocytic leukemia.
P2860
Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Idelalisib Impacts Cell Growth ...... nisms in Mantle Cell Lymphoma.
@en
Idelalisib Impacts Cell Growth ...... nisms in Mantle Cell Lymphoma.
@nl
type
label
Idelalisib Impacts Cell Growth ...... nisms in Mantle Cell Lymphoma.
@en
Idelalisib Impacts Cell Growth ...... nisms in Mantle Cell Lymphoma.
@nl
prefLabel
Idelalisib Impacts Cell Growth ...... nisms in Mantle Cell Lymphoma.
@en
Idelalisib Impacts Cell Growth ...... nisms in Mantle Cell Lymphoma.
@nl
P2093
P2860
P1476
Idelalisib Impacts Cell Growth ...... nisms in Mantle Cell Lymphoma.
@en
P2093
Kim-Anh Do
Lisa S Chen
Min Jin Ha
Qingshan Yang
Sattva S Neelapu
Varsha Gandhi
P2860
P304
P356
10.1158/1078-0432.CCR-15-3135
P407
P577
2016-06-24T00:00:00Z